Browse the corpus

Cryoanalgesia is a specialized technique for providing long-term pain relief in interventional pain management settings. Also known as cryoneuroablation and cryoneurolysis, this technique has historical roots dating back thousands of years. Modern cryoanalgesia, dating to the 1960s, applies freezing temperatures to specific nerves to alleviate persistent and intractable pain. There are multiple clinical applications for this technique. This activity describes the history, techniques, indications, contraindications, and clinical significance of cryoanalgesia, highlighting the potential benefits for both acute and chronic pain conditions. The activity also emphasizes the importance of an interprofessional healthcare team in understanding and implementing cryoanalgesia to improve patient care and outcomes in pain management. Objectives: Identify appropriate candidates for cryoanalgesia based on their clinical presentation, history, and pain characteristics, distinguishing those who may benefit from this intervention. Differentiate between the various clinical conditions and pain etiologies for which cryoanalgesia may be a suitable treatment option while considering alternative pain management approaches. Communicate effectively with patients, providing clear and comprehensive information about the cryoanalgesia procedure, expected outcomes, potential risks, and alternatives. Collaborate with interdisciplinary teams, including anesthesiologists, surgeons, nurses, and physical therapists, to ensure coordinated care for patients undergoing cryoanalgesia. Access free multiple choice questions on this topic.

Using cold temperatures to alleviate pain has a long-standing history in medicine. Hippocrates, the father of medicine, wrote about it thousands of years ago, explaining how snow could ease pain from injuries.[1] In the 1800s, a surgeon general under Napoleon noticed that soldiers who had endured cold weather in Russia felt less pain during amputations.[2] Around this time, topical anesthesia was also discovered in ether and ethyl chloride spray. Cryoanalgesia, or cryoneuroablation or cryoneurolysis, is a specialized technique utilized in interventional pain management to achieve long-term pain relief. The origination of modern cryoanalgesia dates back to 1961 when Cooper et al introduced a device using liquid nitrogen within an insulated tube, capable of reaching a temperature as low as -196 °C.[3] Cryoanalgesia gained prominence in 1976 when Lloyd et al published the first significant paper suggesting its superiority over alternative peripheral nerve destruction methods like alcohol neurolysis, phenol neurolysis, or surgical lesions. In this paper, Lloyd et al demonstrated a significant reduction in intractable pain for 52 of 64 patients treated with cryoanalgesia, including sciatic, intercostal, and facial nerve treatments. The median duration of pain relief was 11 days, with some patients having significant pain relief for up to 224 days.[4] Cryoanalgesia involves the application of cold to tissues (approximately -70 °C) to ablate the targeted nerve, resulting in reversible neuronal injury to the peripheral sensory nerve. This induces a conduction block similar to local anesthetics. The intense cold temperature produces Wallerian degeneration, a reversible breakdown of the nerve axon, inhibiting the transmission of afferent and efferent signals. Because the nerve endoneurium, perineurium, and epineurium remain intact, the axon regenerates along the exoskeleton at approximately 1 to 2 mm/day. Once the axon has regenerated, it reconnects with the sensory receptor, and conduction starts again. Regrowth of axons into the perineurium eventually restores sensation, and the block functionally resolves. Thus, pain sensation may return over time (after weeks to months) and requires repeat administration. Repeating cryoanalgesia in the same anatomic location for subsequent surgical procedures does not result in adverse sequelae.[5]

Cryoanalgesia involves the application of cold to tissues (approximately -70 °C) to ablate the targeted nerve, resulting in reversible neuronal injury to the peripheral sensory nerve. This induces a conduction block similar to local anesthetics. The intense cold temperature produces Wallerian degeneration, a reversible breakdown of the nerve axon, inhibiting the transmission of afferent and efferent signals. Because the nerve endoneurium, perineurium, and epineurium remain intact, the axon regenerates along the exoskeleton at approximately 1 to 2 mm/day. Once the axon has regenerated, it reconnects with the sensory receptor, and conduction starts again. Regrowth of axons into the perineurium eventually restores sensation, and the block functionally resolves. Thus, pain sensation may return over time (after weeks to months) and requires repeat administration. Repeating cryoanalgesia in the same anatomic location for subsequent surgical procedures does not result in adverse sequelae.[5] Cryoanalgesia is an old technique with many possible future applications. Data for cryoanalgesia is encouraging for postoperative pain and in select groups for chronic pain.[6] Clinical applications of cryoanalgesia encompass a wide range of conditions, including craniofacial pain (eg, trigeminal neuralgia, posterior auricular neuralgia, glossopharyngeal neuralgia), chest wall pain (eg, post-thoracotomy neuromas, rib fracture-related pain, post-herpetic neuralgia), abdominal and pelvic pain (eg, ilioinguinal, iliohypogastric, genitofemoral, subgastric neuralgia, pudendal neuralgia), low back and lower extremity pain (eg, lumbar facet joint pathology, pseudosciatica, intraspinous ligament or supragluteal nerve pain, sacroiliac joint pain, cluneal neuralgia, obturator neuritis, peripheral neuropathy), and upper extremity pain (eg, suprascapular neuritis, peripheral neuritis).

Post-procedural complications include the usual complications of interventional procedures: bleeding, infection, and damage to adjacent tissue structures like a muscle (ie, myonecrosis).[21][25] Other potential procedural complications include but are not limited to hypoalgesia, hyperalgesia, allodynia, and prolonged numbness greater than 3 months. With superficial procedures, damage to the skin with resulting alopecia, hyperpigmentation, and hypopigmentation can occur. This damage can be avoided by injecting a saline solution to elevate the skin surface. For intercostal nerves, there are reports of neuroma formation and pneumothorax. If a pneumothorax is caused by needle placement, the expanding gas cooling agent may worsen the pneumothorax. Patients experiencing pneumothorax should be administered 100% oxygen to de-nitrogenate the pneumothorax, mainly if nitrogen was used as the expansion gas.[26]

Cryoanalgesia demands a collaborative and multidisciplinary approach involving physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals, each contributing unique skills and roles to enhance patient-centered care. Physicians and advanced practitioners are responsible for meticulous patient assessment, selection, and procedural expertise. Nurses ensure patient comfort, monitor vital signs and provide essential pre- and post-operative care. Pharmacists play a role in medication management and addressing potential drug interactions. Ethical considerations are integral, with all team members upholding principles of informed consent and respecting patient autonomy. Responsibility for patient safety extends to all, necessitating vigilant monitoring and prompt intervention in case of complications. Effective interprofessional communication ensures seamless coordination, from patient evaluation to post-procedure follow-up. By collectively embracing these responsibilities and roles, healthcare teams can optimize cryoanalgesia outcomes, minimize risks, and prioritize patient well-being while delivering comprehensive pain management solutions.